In addition, our data demonstrated that FTX played its regulatory roles in RB through targeting miR-320a to upregulate the expression of with-no-lysine kinase 1 (WNK1) (graphical abstract), providing a novel insight of FTX in RB. The gene discussed is RB1; the disease is retinoblastoma.